270 related articles for article (PubMed ID: 28714745)
1. Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis.
Yang M; Chen H; Zhang Y; Du Y; Xu Y; Jiang P; Xu Z
Inhal Toxicol; 2017 Apr; 29(5):219-226. PubMed ID: 28714745
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis.
Yang M; Zhang Y; Chen H; Lin J; Zeng J; Xu Z
Infection; 2019 Jun; 47(3):377-385. PubMed ID: 30298471
[TBL] [Abstract][Full Text] [Related]
3. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
Chen H; Feng Y; Wang K; Yang J; Du Y
BMC Pulm Med; 2020 Oct; 20(1):282. PubMed ID: 33115481
[TBL] [Abstract][Full Text] [Related]
4. Intensified Therapy with Inhaled Corticosteroids and Long-Acting β
Stolz D; Hirsch HH; Schilter D; Louis R; Rakic J; Boeck L; Papakonstantinou E; Schindler C; Grize L; Tamm M
Am J Respir Crit Care Med; 2018 May; 197(9):1136-1146. PubMed ID: 29266965
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
Yang M; Du Y; Chen H; Jiang D; Xu Z
Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
[TBL] [Abstract][Full Text] [Related]
6. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials.
Dong YH; Chang CH; Wu FL; Shen LJ; Calverley PMA; Löfdahl CG; Lai MS; Mahler DA
Chest; 2014 Jun; 145(6):1286-1297. PubMed ID: 24504044
[TBL] [Abstract][Full Text] [Related]
7. Risk of adverse reactions associated with inhaled corticosteroids for chronic obstructive pulmonary disease: A meta-analysis.
Lu C; Mao X
Medicine (Baltimore); 2024 Jan; 103(3):e36609. PubMed ID: 38241558
[TBL] [Abstract][Full Text] [Related]
8. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
9. Inhaled Corticosteroids and Mycobacterial Infection in Patients with Chronic Airway Diseases: A Systematic Review and Meta-Analysis.
You Y; Ni Y; Shi G
Respiration; 2022; 101(10):970-980. PubMed ID: 35998604
[TBL] [Abstract][Full Text] [Related]
10. Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.
Liapikou A; Toumbis M; Torres A
Expert Opin Drug Saf; 2015 Aug; 14(8):1237-47. PubMed ID: 26113207
[TBL] [Abstract][Full Text] [Related]
11. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
[TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
13. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
Cave AC; Hurst MM
Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
[TBL] [Abstract][Full Text] [Related]
14. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
Andréjak C; Nielsen R; Thomsen VØ; Duhaut P; Sørensen HT; Thomsen RW
Thorax; 2013 Mar; 68(3):256-62. PubMed ID: 22781123
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
Cheng SL; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
[TBL] [Abstract][Full Text] [Related]
17. Use of inhaled corticosteroids in COPD: improving efficacy.
Yang IA; Shaw JG; Goddard JR; Clarke MS; Reid DW
Expert Rev Respir Med; 2016; 10(3):339-50. PubMed ID: 26855301
[TBL] [Abstract][Full Text] [Related]
18. Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non-randomized Studies.
Castellana G; Castellana M; Castellana C; Castellana G; Resta E; Carone M; Resta O
Int J Chron Obstruct Pulmon Dis; 2019; 14():2219-2227. PubMed ID: 31576118
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids in COPD and the risk of lung cancer.
Lee YM; Kim SJ; Lee JH; Ha E
Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
[TBL] [Abstract][Full Text] [Related]
20. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
